S-1 registration
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 33 of Skye Bioscience, Inc.'s SEC filings and found 9 warrant series, 1 convertible, 1 ATM program, 1 equity line, 2 shelf registrations, 1 S-1 registration and 1 completed offering on file for SKYE. Analysis updated Oct 5, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 · latest dilution event 81 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 14, 2026 · Offering Priced
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Proposed maximum
Shares registered
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Principal
Conversion Price
Issued 2024
Total capacity
Sold to date
Issued 2026
Commitment
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z